Literature DB >> 31758443

Cytokine levels predict 30-day mortality in octogenarians and nonagenarians with community-acquired pneumonia: a retrospective observational study.

Héctor Pinargote-Celorio1, Gemma Miralles2, Miguel Cano2, Esther Caparros2, Joaquín Portilla3,2,4, Gregorio González-Alcaide5, José M Ramos Rincón3,2.   

Abstract

To analyze the value of cytokines (tumor necrosis factor [TNF]-α, interleukin [IL]-1β, IL-6, IL-8, IL-10) as predictors of mortality at 30 days in octogenarians and nonagenarians hospitalized in an internal medicine unit for community-acquired pneumonia (CAP). An observational, analytical, retrospective cohort study was conducted in the Department of Internal Medicine at Alicante General University Hospital between January 2014 and December 2015. Blood samples were frozen at - 80 °C, and cytokines were measured by ELISA. We included 115 patients, of whom 54% were men, with a mean age of 86.4 (standard deviation 4.5) years. There is a moderate correlation between IL-10 levels and CURB-65 score (p < 0.001) and a weak correlation with creatinine levels (p = 0.012) and urea levels (p = 0.032). Forty-five (39.1%) patients died within 30 days. In a multivariate analysis, the variables associated with mortality at 30 days were the following: age (adjusted odds ratio [ORa] 1.134, 95% confidence interval [CI] 1.02, 1.26), male sex (ORa 2.85, 95% CI 1.14, 7.14), IL-8 of 19 pg/mL or more (ORa 4.09, 95% CI 1.67, 10.01), and IL-10 of 11.29 pg/mL or more (ORa 4.00, 95% CI 1.58, 10.12). High IL-8 and IL-10 levels were shown to predict 30-day mortality in elderly patients with CAP. The inflammatory response in these patients seems to condition their prognosis. Further research in this line would provide more understanding about the physiopathological mechanisms and potential therapeutic targets for improving survival.

Entities:  

Keywords:  Aged 80 and over; Community acquired pneumonia; Interleukin-10; Interleukin-8; Mortality

Mesh:

Substances:

Year:  2019        PMID: 31758443     DOI: 10.1007/s10096-019-03725-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  Interleukin-8 in sepsis: relation to shock and inflammatory mediators.

Authors:  C E Hack; M Hart; R J van Schijndel; A J Eerenberg; J H Nuijens; L G Thijs; L A Aarden
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Age group analysis of psychological, physical and functional deterioration in patients hospitalized for pneumonia.

Authors:  Adelina Martín-Salvador; Irene Torres-Sánchez; Germán Sáez-Roca; Isabel López-Torres; Elisabeth Rodríguez-Alzueta; Marie Carmen Valenza
Journal:  Arch Bronconeumol       Date:  2015-01-17       Impact factor: 4.872

3.  Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.

Authors:  John A Kellum; Lan Kong; Mitchell P Fink; Lisa A Weissfeld; Donald M Yealy; Michael R Pinsky; Jonathan Fine; Alexander Krichevsky; Russell L Delude; Derek C Angus
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

4.  Geriatric assessment and prognostic factors of mortality in very elderly patients with community-acquired pneumonia.

Authors:  Alicia Calle; Miguel Angel Márquez; Marta Arellano; Laura Mónica Pérez; Maria Pi-Figueras; Ramón Miralles
Journal:  Arch Bronconeumol       Date:  2014-03-12       Impact factor: 4.872

5.  The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.

Authors:  W-Y Niu; Y-G Wan; M-Y Li; Z-X Wu; L-G Zhang; J-X Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-12       Impact factor: 3.507

Review 6.  Innate immunesenescence: underlying mechanisms and clinical relevance.

Authors:  Jon Hazeldine; Janet M Lord
Journal:  Biogerontology       Date:  2014-07-10       Impact factor: 4.277

7.  Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ.

Authors:  Katrin Zobel; Peter Martus; Mathias W Pletz; Santiago Ewig; Michael Prediger; Tobias Welte; Frank Bühling
Journal:  BMC Pulm Med       Date:  2012-02-20       Impact factor: 3.317

8.  IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients.

Authors:  M R Bacci; R C P Leme; N P C Zing; N Murad; F Adami; P F Hinnig; D Feder; A C P Chagas; F L A Fonseca
Journal:  Braz J Med Biol Res       Date:  2015-02-24       Impact factor: 2.590

9.  Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients.

Authors:  Alexander Kutz; Eva Grolimund; Mirjam Christ-Crain; Robert Thomann; Claudine Falconnier; Claus Hoess; Christoph Henzen; Werner Zimmerli; Beat Mueller; Philipp Schuetz
Journal:  BMC Anesthesiol       Date:  2014-11-15       Impact factor: 2.217

10.  Associations between biomarkers at discharge and co-morbidities and risk of readmission after community-acquired pneumonia: a retrospective cohort study.

Authors:  Pelle Trier Petersen; Gertrud Baunbæk Egelund; Andreas Vestergaard Jensen; Stine Bang Andersen; Merete Frejstrup Pedersen; Gernot Rohde; Pernille Ravn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-29       Impact factor: 3.267

View more
  4 in total

1.  Ulinastatin plus biapenem for severe pneumonia in the elderly and its influence on pulmonary function and inflammatory cytokines.

Authors:  Rui Zhang; Jitao Ma; Pengxiao Zheng; Ruirui Zheng; Xu Meng; Yinjia Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Comparison of clinical characteristics and inflammatory cytokines between hypoxemic and non-hypoxemic human adenovirus 55 pneumonia.

Authors:  Jeong Uk Lim; Joon Young Choi; Ho Jung Jeong; Jae-Hoon Ko; Ji Eun Lee; Chin Kook Rhee
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

3.  Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia.

Authors:  Astrid Malézieux-Picard; Leire Azurmendi; Sabrina Pagano; Nicolas Vuilleumier; Jean-Charles Sanchez; Dina Zekry; Jean-Luc Reny; Jérôme Stirnemann; Nicolas Garin; Virginie Prendki
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

4.  Diagnostic potential of circulating cell-free microRNAs for community-acquired pneumonia and pneumonia-related sepsis.

Authors:  Stefanie Hermann; Florian Brandes; Benedikt Kirchner; Dominik Buschmann; Melanie Borrmann; Matthias Klein; Stefan Kotschote; Michael Bonin; Marlene Reithmair; Ines Kaufmann; Gustav Schelling; Michael W Pfaffl
Journal:  J Cell Mol Med       Date:  2020-09-11       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.